Biochemistry and therapeutics of posthypoxic myoclonus.
作者信息
Van Woert M H, Rosenbaum D, Chung E Y
出版信息
Adv Neurol. 1986;43:171-81.
PMID:2418644
Abstract
摘要
相似文献
1
Biochemistry and therapeutics of posthypoxic myoclonus.
Adv Neurol. 1986;43:171-81.
2
Treatment of posthypoxic action myoclonus: implications for the pathophysiology of the disorder.
Adv Neurol. 1986;43:183-90.
3
Beneficial effects of serotonin precursors in postanoxic action myoclonus.
Neurology. 1976 Sep;26(9):863-8. doi: 10.1212/wnl.26.9.863.
4
Possible mechanisms of action of valproic acid in myoclonus.
Adv Neurol. 1986;43:653-60.
5
Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486.
Neurology. 1975 Feb;25(2):135-40. doi: 10.1212/wnl.25.2.135.
6
Clinical, biochemical, and pharmacological observation in a patient with postasphyxic myoclonus: association to serotonin hyperactivity.
Clin Neuropharmacol. 1988 Apr;11(2):151-60. doi: 10.1097/00002826-198804000-00006.
7
Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam.
Brain. 1977 Sep;100(3):455-87. doi: 10.1093/brain/100.3.455.
8
9
Letter: Treatment of post-anoxic intention myoclonus.
Lancet. 1974 Jun 22;1(7869):1285. doi: 10.1016/s0140-6736(74)90035-x.
10
Post-hypoxic intention myoclonus treated with 5-hydroxy-tryptophan and an extracerebral decarboxylase inhibitor.
Acta Neurol Scand. 1978 Apr;57(4):289-94. doi: 10.1111/j.1600-0404.1978.tb04502.x.
引用本文的文献
1
Allelic variation in the serotonin transporter promoter affects neuromodulatory effects of a selective serotonin transporter reuptake inhibitor (SSRI).
Psychopharmacology (Berl). 2003 Mar;166(3):294-7. doi: 10.1007/s00213-002-1370-1. Epub 2003 Feb 1.
Zotero 插件